Examination of the District of Columbia’s Highway Trust Fund Forecast Statements for FYs 2014 – 2018 with Actual Audit Figures for FY 2013 Read more about Examination of the District of Columbia’s Highway Trust Fund Forecast Statements for FYs 2014 – 2018 with Actual Audit Figures for FY 2013
District Department of Transportation - Highway Trust Fund Financial Statement Audit - For the Fiscal Year Ended September 30, 2013 Read more about District Department of Transportation - Highway Trust Fund Financial Statement Audit - For the Fiscal Year Ended September 30, 2013
Audit of DOH's Non-Emergency Transportation Read more about Audit of DOH's Non-Emergency Transportation
Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Mail Fraud for Defrauding the DC Department of Employment Services Read more about Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Mail Fraud for Defrauding the DC Department of Employment Services
Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Fraud in the Second Degree for Defrauding the DC Department of Employment Services Read more about Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Fraud in the Second Degree for Defrauding the DC Department of Employment Services
Independent Auditors’ Report on Internal Control Over Financial Reporting and on Compliance and Other Matters for the Fiscal Year Ended September 30, 2013 Read more about Independent Auditors’ Report on Internal Control Over Financial Reporting and on Compliance and Other Matters for the Fiscal Year Ended September 30, 2013
Genzyme Corp. to Pay $22.28 Million to Resolve False Claims Allegations Related to “Slurry” Used in Patients Read more about Genzyme Corp. to Pay $22.28 Million to Resolve False Claims Allegations Related to “Slurry” Used in Patients Genzyme Corp. to Pay $22.28 Million to Resolve False Claims Allegations Related to “Slurry” Used in Patients
Omnicare, Inc. Agrees to Pay Medicaid Program Over $3.8 Million to Resolve Illegal Kickback Case Read more about Omnicare, Inc. Agrees to Pay Medicaid Program Over $3.8 Million to Resolve Illegal Kickback Case Omnicare, Inc. Agrees to Pay Medicaid Program Over $3.8 Million to Resolve Illegal Kickback Case
Endo Pharmaceuticals to Pay $172.9 Million to Resolve Off Label Marketing Read more about Endo Pharmaceuticals to Pay $172.9 Million to Resolve Off Label Marketing Endo Pharmaceuticals to Pay $172.9 Million to Resolve Off Label Marketing
Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Fraud in the Second Degree for Defrauding the Department of Employment Services Read more about Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Fraud in the Second Degree for Defrauding the Department of Employment Services